2023
DOI: 10.1007/s11255-022-03456-2
|View full text |Cite
|
Sign up to set email alerts
|

Bibliometric analysis of ferroptosis in acute kidney injury from 2014 to 2022

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 68 publications
0
5
0
Order By: Relevance
“…The trend topic map showed that frontiers of AKI biomarkers were concentrated on ferroptosis, renal fibrosis, COVID-19, and machine-learning-based prediction models. Congruently, a recent bibliometric analysis of ferroptosis in AKI showed that the study of ferroptosis in AKI is still in its infancy, and the crosstalk between ferroptosis and other types of programmed cell death would be a hotspot for future research [ 32 ]. Moreover, ferroptosis has also been implicated in the transition from AKI to chronic kidney disease, and regulating ferroptosis would be a promising strategy to halt this transition [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…The trend topic map showed that frontiers of AKI biomarkers were concentrated on ferroptosis, renal fibrosis, COVID-19, and machine-learning-based prediction models. Congruently, a recent bibliometric analysis of ferroptosis in AKI showed that the study of ferroptosis in AKI is still in its infancy, and the crosstalk between ferroptosis and other types of programmed cell death would be a hotspot for future research [ 32 ]. Moreover, ferroptosis has also been implicated in the transition from AKI to chronic kidney disease, and regulating ferroptosis would be a promising strategy to halt this transition [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Table 3 shows the top 10 authors in terms of number of publications and co-citation frequency. The author with the highest number of publications and cocitation frequency in the field is the same author Acharya, U. Rajendra of Ngee Ann Polytechnic, Singapore (17,489), which is a good indication of his academic standing in the field of ML and epilepsy. This is followed by Loddenkemper, Tobias of Harvard Medical School, Boston, Massachusetts, USA (13) and Brinkmann, Benjamin H. of Mayo Clinic, Rochester, MN, USA (13), who rank second in terms of number of publications.…”
Section: Distribution Of Authorsmentioning
confidence: 94%
“…It not only provides a basis for researchers to analyze the hotspots and development trends of the discipline and predict the direction of development of the discipline, but also provides a reference for the construction of the discipline and training of talents in the hospital. It further provides active research institutions and groups that can facilitate potential international or national research collaborations (15)(16)(17)(18). Despite the rapid development of research related to the application of ML in epilepsy, there is still a lack of bibliometric analysis related to this field.…”
Section: Introductionmentioning
confidence: 99%
“…Ferroptosis has been implicated in the progression of various diseases, including cardiovascular diseases, neurodegenerative diseases, chronic kidney diseases, skin diseases, and others 17–19 . DAZ‐associated protein 1 (DAZAP1) is recognized as a potent suppressor of ferroptosis.…”
Section: Role Of Ferroptosis In Diseasementioning
confidence: 99%
“…Ferroptosis has been implicated in the progression of various diseases, including cardiovascular diseases, neurodegenerative diseases, chronic kidney diseases, skin diseases, and others. 17 , 18 , 19 DAZ‐associated protein 1 (DAZAP1) is recognized as a potent suppressor of ferroptosis. In hepatocellular carcinoma (HCC) cells, DAZAP1 was shown to bind to SLC7A11 mRNA, positively regulating SLC7A11 expression and inhibiting ferroptosis.…”
Section: Role Of Ferroptosis In Diseasementioning
confidence: 99%